A Network Pharmacology Study on the Cervix Prescription for Treatment of Cervical Cancer

Figure 9

Immunohistochemical results: observed under the microscope, the positive was brown or yellowish brown. lncRNA-ATB promotes the growth of cervical cancer in vivo and the inhibitory effect of CP on lncRNA-ATB (c), TGF-β1 (a, d), and CD31 (b).